GEODE CAPITAL MANAGEMENT, LLC - AVIRAGEN THERAPEUTICS INC ownership

AVIRAGEN THERAPEUTICS INC's ticker is AVIR and the CUSIP is 053761102. A total of 32 filers reported holding AVIRAGEN THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of AVIRAGEN THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$94,000
-17.5%
167,3230.0%0.00%
Q3 2017$114,000
+1.8%
167,3230.0%0.00%
Q2 2017$112,000
-3.4%
167,323
-6.4%
0.00%
Q1 2017$116,000
-46.5%
178,689
+0.9%
0.00%
Q4 2016$217,000
-35.8%
177,141
+0.6%
0.00%
Q3 2016$338,000
+37.4%
176,109
+0.1%
0.00%
Q2 2016$246,000175,8510.00%
Other shareholders
AVIRAGEN THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 2,836,326$1,899,0000.58%
ARMISTICE CAPITAL, LLC 1,122,829$752,0000.10%
TOWERVIEW LLC 175,000$117,0000.06%
Carlson Capital Management 156,485$105,0000.03%
GABELLI & Co INVESTMENT ADVISERS, INC. 224,477$150,0000.02%
Tower Research Capital LLC (TRC) 49,186$33,0000.00%
Virtu KCG Holdings LLC 222,934$149,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 204,470$137,0000.00%
Renaissance Technologies 1,058,103$708,0000.00%
WEDBUSH SECURITIES INC 14,131$9,0000.00%
View complete list of AVIRAGEN THERAPEUTICS INC shareholders